189 related articles for article (PubMed ID: 24193570)
1. Pharmacogenetic effects of regulatory nuclear receptors (PXR, CAR, RXRα and HNF4α) on docetaxel disposition in Chinese nasopharyngeal cancer patients.
Chew SC; Lim J; Singh O; Chen X; Tan EH; Lee EJ; Chowbay B
Eur J Clin Pharmacol; 2014 Feb; 70(2):155-66. PubMed ID: 24193570
[TBL] [Abstract][Full Text] [Related]
2. Influence of SLCO1B3 haplotype-tag SNPs on docetaxel disposition in Chinese nasopharyngeal cancer patients.
Chew SC; Sandanaraj E; Singh O; Chen X; Tan EH; Lim WT; Lee EJ; Chowbay B
Br J Clin Pharmacol; 2012 Apr; 73(4):606-18. PubMed ID: 21995462
[TBL] [Abstract][Full Text] [Related]
3. PXR, CAR and HNF4alpha genotypes and their association with pharmacokinetics and pharmacodynamics of docetaxel and doxorubicin in Asian patients.
Hor SY; Lee SC; Wong CI; Lim YW; Lim RC; Wang LZ; Fan L; Guo JY; Lee HS; Goh BC; Tan T
Pharmacogenomics J; 2008 Apr; 8(2):139-46. PubMed ID: 17876342
[TBL] [Abstract][Full Text] [Related]
4. Lack of association of single-nucleotide polymorphisms in pregnane X receptor, hepatic nuclear factor 4alpha, and constitutive androstane receptor with docetaxel pharmacokinetics.
Tham LS; Holford NH; Hor SY; Tan T; Wang L; Lim RC; Lee HS; Lee SC; Goh BC
Clin Cancer Res; 2007 Dec; 13(23):7126-32. PubMed ID: 18056193
[TBL] [Abstract][Full Text] [Related]
5. Genetic variations of NR1I3 and NR2B1 in Asian populations.
Chew SC; Lim JS; Singh O; Wong M; Lee EJ; Chowbay B
Drug Metab Pharmacokinet; 2013; 28(2):169-76. PubMed ID: 22850739
[TBL] [Abstract][Full Text] [Related]
6. The effects of CYP3A4, CYP3A5, ABCB1, ABCC2, ABCG2 and SLCO1B3 single nucleotide polymorphisms on the pharmacokinetics and pharmacodynamics of docetaxel in nasopharyngeal carcinoma patients.
Chew SC; Singh O; Chen X; Ramasamy RD; Kulkarni T; Lee EJ; Tan EH; Lim WT; Chowbay B
Cancer Chemother Pharmacol; 2011 Jun; 67(6):1471-8. PubMed ID: 21468756
[TBL] [Abstract][Full Text] [Related]
7. PXR and CAR single nucleotide polymorphisms influence plasma efavirenz levels in South African HIV/AIDS patients.
Swart M; Whitehorn H; Ren Y; Smith P; Ramesar RS; Dandara C
BMC Med Genet; 2012 Nov; 13():112. PubMed ID: 23173844
[TBL] [Abstract][Full Text] [Related]
8. Nuclear receptors and drug metabolism for the personalization of cancer therapy.
Cecchin E; De Mattia E; Toffoli G
Expert Opin Drug Metab Toxicol; 2016; 12(3):291-306. PubMed ID: 26789519
[TBL] [Abstract][Full Text] [Related]
9. Genetic variations of NR2A1 in Asian populations: implications in pharmacogenetics studies.
Chew SC; Lim JS; Lee EJ; Chowbay B
Drug Metab Pharmacokinet; 2013; 28(3):278-88. PubMed ID: 23268925
[TBL] [Abstract][Full Text] [Related]
10. SLC22A1-ABCB1 haplotype profiles predict imatinib pharmacokinetics in Asian patients with chronic myeloid leukemia.
Singh O; Chan JY; Lin K; Heng CC; Chowbay B
PLoS One; 2012; 7(12):e51771. PubMed ID: 23272163
[TBL] [Abstract][Full Text] [Related]
11. Effect of Single Nucleotide Polymorphisms in the Xenobiotic-sensing Receptors NR1I2 and NR1I3 on the Pharmacokinetics and Toxicity of Irinotecan in Colorectal Cancer Patients.
Mbatchi LC; Robert J; Ychou M; Boyer JC; Del Rio M; Gassiot M; Thomas F; Tubiana N; Evrard A
Clin Pharmacokinet; 2016 Sep; 55(9):1145-57. PubMed ID: 27116457
[TBL] [Abstract][Full Text] [Related]
12. Genetic polymorphisms of CYP1A2, CYP3A4, CYP3A5, pregnane/steroid X receptor and constitutive androstane receptor in 207 healthy Spanish volunteers.
Oliver P; Lubomirov R; Carcas A
Clin Chem Lab Med; 2010 May; 48(5):635-9. PubMed ID: 20218903
[TBL] [Abstract][Full Text] [Related]
13. Genetic variations of the xenoreceptors NR1I2 and NR1I3 and their effect on drug disposition and response variability.
Mbatchi LC; Brouillet JP; Evrard A
Pharmacogenomics; 2018 Jan; 19(1):61-77. PubMed ID: 29199543
[TBL] [Abstract][Full Text] [Related]
14. Genetic associations of docetaxel-based chemotherapy-induced myelosuppression in Chinese Han population.
Ren W; Zhou C; Liu Y; Su K; Jia L; Chen L; Li M; Ma J; Zhou W; Zhang S; Zhang D; Cong Z; Niu X; Zhang S; Shen L; Huai C; Sun X; Li G; Qin S; Guo L
J Clin Pharm Ther; 2020 Apr; 45(2):354-364. PubMed ID: 31778586
[TBL] [Abstract][Full Text] [Related]
15. Pharmacogenetics of irinotecan, doxorubicin and docetaxel transporters in Asian and Caucasian cancer patients: a comparative review.
Chen S; Sutiman N; Zhang CZ; Yu Y; Lam S; Khor CC; Chowbay B
Drug Metab Rev; 2016 Nov; 48(4):502-540. PubMed ID: 27546072
[TBL] [Abstract][Full Text] [Related]
16. Pharmacogenetic screening of CYP3A and ABCB1 in relation to population pharmacokinetics of docetaxel.
Bosch TM; Huitema AD; Doodeman VD; Jansen R; Witteveen E; Smit WM; Jansen RL; van Herpen CM; Soesan M; Beijnen JH; Schellens JH
Clin Cancer Res; 2006 Oct; 12(19):5786-93. PubMed ID: 17020985
[TBL] [Abstract][Full Text] [Related]
17. Association of Hepatic Nuclear Factor 4 Alpha Gene Polymorphisms With Free Imatinib Plasma Levels and Adverse Reactions in Chinese Gastrointestinal Stromal Tumor Patients.
Chen H; Liu J; Zhou Y; Hou Y; Ma G; Cai W
Ther Drug Monit; 2019 Oct; 41(5):582-590. PubMed ID: 31045869
[TBL] [Abstract][Full Text] [Related]
18. Genetic variants of PXR (NR1I2) and CAR (NR1I3) and their implications in drug metabolism and pharmacogenetics.
Lamba J; Lamba V; Schuetz E
Curr Drug Metab; 2005 Aug; 6(4):369-83. PubMed ID: 16101575
[TBL] [Abstract][Full Text] [Related]
19. Association of xenobiotic receptor polymorphisms with carbamazepine response in epilepsy patients.
Kong FC; Ma CL; Lang LQ; Zhong MK
Gene; 2021 Mar; 771():145359. PubMed ID: 33333223
[TBL] [Abstract][Full Text] [Related]
20. Effects of Polymorphisms in NR1H4, NR1I2, SLCO1B1, and ABCG2 on the Pharmacokinetics of Rosuvastatin in Healthy Chinese Volunteers.
Liu M; Wu XJ; Zhao GL; Zhang T; Xu SS; Sun YX; Qiu F; Zhao LM
J Cardiovasc Pharmacol; 2016 Nov; 68(5):383-390. PubMed ID: 27557342
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
